| 1 |
19650625 | Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9. | 2009 Aug 27 |
1 |
| 2 |
17671391 | Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN. | 2007 |
1 |
| 3 |
15010828 | Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs. | 2004 Apr |
1 |
| 4 |
12804862 | CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum. | 2003 Jul 4 |
1 |
| 5 |
12198661 | Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. | 2002 Sep |
1 |
| 6 |
12236778 | Conjugation of ligands at the 5'-end of CpG DNA affects immunostimulatory activity. | 2002 Sep-Oct |
1 |
| 7 |
11413315 | CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice. | 2001 Jul |
1 |
| 8 |
10903720 | CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 predisposition to antigen-driven responses. | 2000 Aug 1 |
1 |